Abstract
Alpha-fetoprotein (AFP)-producing adenocarcinoma is known for its rapid progression and poor prognosis, and chemotherapy regimens are yet to be standardized. Here we describe the first report of AFP-producing adenocarcinoma with calcification. The metastatic route was visualized from the calcification, and combination chemotherapy was performed. A 77-year-old Japanese man was transferred to our hospital for treatment of liver tumors. Computed tomography (CT) revealed multiple liver tumors with portal vein tumor thrombosis. The tumors were highly attenuated before enhancement, suggesting various degrees of calcification. Serum levels of carcinoembryonic antigen (CEA), AFP, and the proportion of fucosylated AFP were considerably elevated. Gastroduodenoscopy revealed an elevated tumor occupying the duodenal bulb with an ulcerative lesion in the vicinity of the gastroduodenal junction, and biopsy specimens from the duodenum and liver revealed medullary adenocarcinoma with calcification. Three-dimensional reconstruction of CT images clearly showed that the calcified lesions had spread from the gastroduodenal junction to the liver via a route comprising the corresponding local vein, the superior mesenteric vein, and portal vein. The patient was accordingly diagnosed with calcified AFP-producing adenocarcinoma with multiple liver metastases. Combination chemotherapy using TS-1 and cisplatin (CDDP) resulted in a striking response for the initial 4 months in terms of tumor markers and CT findings. This is the first report of AFP-producing adenocarcinoma with calcification. A metastatic route from the primary tumor to the liver was clearly visualized by tracing the calcified lesions. Combination chemotherapy based on 5-fluorouracil and CDDP may have the potential to prolong survival.
Similar content being viewed by others
References
Gitlin D, Perricelli A, Gitlin GM. Synthesis of alpha-fetoprotein by liver, yolk sac, and gastrointestinal tract of the human conceptus. Cancer Res. 1972;32:979–82.
Purves LR, Bersohn I, Geddes EW. Serum alpha-feto-protein and primary cancer of the liver in man. Cancer. 1970;25:1261–70.
Umeda K, Heike T, Yoshimoto M, Shiota M, Suemori H, Luo HY, et al. Development of primitive and definitive hematopoiesis from nonhuman primate embryonic stem cells in vitro. Development. 2004;131:1869–79.
Bourreille J, Metayer P, Sauger F, Matray F, Fondimare A. Existence of alpha feto protein during gastric-origin secondary cancer of the liver. Presse Med. 1970;78:1277–8.
Takashima H, Kimura H, Nakamura H, Myojo S, Okuyama Y, Sugeta N, et al. A case of AFP producing endocrine cell carcinoma of the duodenum. Nippon Shokakibyo Gakkai Zasshi. 2002;99:798–802.
Gardiner GW, Lajoie G, Keith R. Hepatoid adenocarcinoma of the papilla of Vater. Histopathology. 1992;20:541–4.
Iwai K, Ishikura H, Inoue T, Yoshiki T. A case of AFP-positive pancreas papillary carcinoma suggestive of a primitive endoderm phenotype. Acta Pathol Jpn. 1993;43:434–9.
Tanno S, Obara T, Fujii T, Izawa T, Mizukami Y, Saitoh Y, et al. alpha-Fetoprotein-producing adenocarcinoma of the pancreas presenting focal hepatoid differentiation. Int J Pancreatol. 1999;26:43–7.
Alpert E, Pinn VW, Isselbacher KJ. Alpha-fetoprotein in a patient with gastric carcinoma metastatic to the liver. N Engl J Med. 1971;285:1058–9.
Inagawa S, Shimazaki J, Hori M, Yoshimi F, Adachi S, Kawamoto T, et al. Hepatoid adenocarcinoma of the stomach. Gastric Cancer. 2001;4:43–52.
Chang YC, Nagasue N, Kohno H, Taniura H, Uchida M, Yamanoi A, et al. Clinicopathologic features and long-term results of alpha-fetoprotein-producing gastric cancer. Am J Gastroenterol. 1990;85:1480–5.
Koide N, Nishio A, Igarashi J, Kajikawa S, Adachi W, Amano J. Alpha-fetoprotein-producing gastric cancer: histochemical analysis of cell proliferation, apoptosis, and angiogenesis. Am J Gastroenterol. 1999;94:1658–63.
Ihling C, Schaefer HE, Baumgartner U, Riede UN. Hepatoid adenocarcinoma of the stomach: a case report. Gen Diagn Pathol. 1995;141:61–5.
Kochi M, Fujii M, Kaiga T, Takahashi T, Morishita Y, Kobayashi M, et al. FLEP chemotherapy for alpha-fetoprotein-producing gastric cancer. Oncology. 2004;66:445–9.
Nakajima T, Ota K, Ishihara S, Oyama S, Nishi M, Ohashi Y, et al. Combined intensive chemotherapy and radical surgery for incurable gastric cancer. Ann Surg Oncol. 1997;4:203–8.
Shimada S, Hayashi N, Marutsuka T, Baba Y, Yokoyama S, Iyama K, et al. Irinotecan plus low-dose cisplatin for alpha-fetoprotein-producing gastric carcinoma with multiple liver metastases: report of two cases. Surg Today. 2002;32:1075–80.
Shiochi H, Yamada M, Kishina M, Murawaki Y, Miura M, Azumi T, et al. A case of AFP-producing gastric cancer responding to the combination of systemic chemotherapy, transcatheter arterial embolization and hepatic infusion chemotherapy. Gan To Kagaku Ryoho. 2009;36:843–6.
Takeyama H, Sawai H, Wakasugi T, Takahashi H, Matsuo Y, Ochi N, et al. Successful paclitaxel-based chemotherapy for an alpha-fetoprotein-producing gastric cancer patient with multiple liver metastases. World J Surg Oncol. 2007;5:79.
Usuba T, Toyama Y, Watanabe K, Kashiwagi H, Yanaga K. Combination chemotherapy using TS-1, paclitaxel and cisplatin for multiple lung metastases from AFP-producing gastric cancer: a case report. Hepatogastroenterology. 2007;54:1302–4.
Motoyama T, Aizawa K, Watanabe H, Fukase M, Saito K. Alpha-fetoprotein producing gastric carcinomas: a comparative study of three different subtypes. Acta Pathol Jpn. 1993;43:654–61.
Ichiishi E, Kogawa T, Takeda S, Yanagida K, Yoshikawa T, Kondo M. Eight cases of gastric tumors with calcification. Intern Med. 1995;34:1038–42.
Michelassi F, Takanishi DM Jr, Pantalone D, Hart J, Chappell R, Block GE. Analysis of clinicopathologic prognostic features in patients with gastric adenocarcinoma. Surgery. 1994;116:804–9. discussion 809–10.
Glockzin G, Schlitt HJ, Piso P. Peritoneal carcinomatosis: patients selection, perioperative complications and quality of life related to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. World J Surg Oncol. 2009;7:5.
Aoyagi Y, Suzuki Y, Igarashi K, Saitoh A, Oguro M, Yokota T, et al. The usefulness of simultaneous determinations of glucosaminylation and fucosylation indices of alpha-fetoprotein in the differential diagnosis of neoplastic diseases of the liver. Cancer. 1991;67:2390–4.
Amemiya H, Kono K, Mori Y, Takahashi A, Ichihara F, Iizuka H, et al. High frequency of c-Met expression in gastric cancers producing alpha-fetoprotein. Oncology. 2000;59:145–51.
Kamei S, Kono K, Amemiya H, Takahashi A, Sugai H, Ichihara F, et al. Evaluation of VEGF and VEGF-C expression in gastric cancer cells producing alpha-fetoprotein. J Gastroenterol. 2003;38:540–7.
Kono K, Amemiya H, Sekikawa T, Iizuka H, Takahashi A, Fujii H, et al. Clinicopathologic features of gastric cancers producing alpha-fetoprotein. Dig Surg. 2002;19:359–65. discussion 365.
Koizumi W, Narahara H, Hara T, Takagane A, Akiya T, Takagi M, et al. S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial. Lancet Oncol. 2008;9:215–21.
Sohda T, Hanano T, Miyamoto H, Kitano Y, Iwata K, Yokoyama M, et al. Spontaneous rupture of metastatic alpha-fetoprotein-producing gastric cancer of the liver. Hepatol Int. 2008;2:258–61.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tsuchiya, A., Kanefuji, T., Suda, T. et al. Alpha-fetoprotein-producing adenocarcinoma in which the metastatic route was determined from calcified lesions. Clin J Gastroenterol 4, 89–94 (2011). https://doi.org/10.1007/s12328-011-0209-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12328-011-0209-x